Overview
Realcan (002589)
Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institutions in China. It operates through the Drug...
- Open
- 2.75
- High
- 2.78
- Low
- 2.71
- Prev. Close
- 2.76
- Volume
- 269.39K
- Turnover
- 73.99M
- Avg Price
- 2.75
- Bid/Ask Ratio
- --
- Amplitude
- 2.54%
- 52wk High
- 4.69
- Volume Ratio
- 0.00
- Turnover Ratio
- 1.79%
- 52wk Low
- 2.38
- Float Mkt Cap
- 4.08B
- Market CapCNY
- 4.08B
- P/ETTM
- 308.99
- P/EDynamic
- 330.18
- P/EStatic
- --
- EPSTTM
- 0.0088
- EPSDynamic
- 0.0082
- EPSStatic
- --
- BVPS
- 3.53
- P/B
- 0.77
- Circulating Supply
- 1.50B
- Dividend YieldTTM
- 0.07%
- DividendTTM
- 0.00
- Shares
- 1.50B
- Min lot size
- 100
- Currency
- CNY
Realcan Analyst Rating
View moreForecast & Rating
Jul 1, 2021- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
Quartr · ALCA: Adjusted EBITA rose 17% as data center demand drove growth and working capital reached record efficiency
Wallstreetcn · A-share Three Major Indices Fell Collectively, Computing Hardware Active Against the Trend, Hang Seng Tech Index Down Over 1%, AI Large Model Stocks Rebound, KNOWLEDGE ATLAS Rises 7%
Wallstreetcn · Pharmaceutical commercial stocks are repeatedly active, NEPTUNUS has a 6-day consecutive limit-up, Realcan hits the limit-up, HRPC, SHKK, INT'L GROUP, and others follow suit. In news, China's drug price registration system has officially launched
Zhitong · Realcan: Net profit loss of 6.0298 million yuan in the third quarter
Zhitong · Realcan: The company's director, board secretary, and vice president Li Zhe has been released from detention and changed to a directive for further investigation
Zhitong · Realcan: Han Chunlin resigns as director and vice president
